A large national study of ferritin testing in Canadian blood donors

Transfusion

Volumn 57, Issue 3, 2017, Pages 564-570

  Goldman, Mindy ^a   Uzicanin, Samra ^a   Osmond, Lori ^a   Scalia, Vito ^a   O'Brien, Sheila F ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; CANADIAN; FEMALE; FERRITIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; IRON DEFICIENCY; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; MINERAL SUPPLEMENTATION; BLOOD; CANADA; DONOR SELECTION; MIDDLE AGED; SEX DIFFERENCE; TIME FACTOR;

ADOLESCENT; ADULT; BLOOD DONORS; CANADA; DONOR SELECTION; FEMALE; FERRITINS; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; TIME FACTORS;

EID: 85006747526     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13956     Document Type: Article

References (19)

1. AABB Association Bulletin #12-03: Strategies to monitor, limit, or prevent iron deficiency in blood donors [Internet]. Bethesda: AABB; 2012 [cited 2016 Aug 29]. Available from http://www.aabb.org/programs/publications/bulletins/Pages/ab12-03.aspx.
2. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2012;52:702-11.
3. Salvin HE, Pasricha SR, Marks DC, et al. Iron deficiency in blood donors: a national cross-sectional study. Transfusion 2014;54:2434-44.
4. Rigas AS, Sørensen CJ, Petersen MS, et al. Predictors of iron levels in 14,737 Danish blood donors: results from the Danish blood donor study. Transfusion 2014;54:789-96.
5. Baart AM, van Noord PA, Vergouwe Y, et al. High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin. Transfusion 2013;53:1670-7.
6. Magnussen K, Ladelund S. Handling low hemoglobin and iron deficiency in a blood donor population: 2 years' experience. Transfusion 2015;55:2473-8.
7. O'Meara A, Infanti L, Stebler C, et al. The value of routine ferritin measurement in blood donors. Transfusion 2011;51:2183-8.
8. Bryant BJ, Yau YY, Arceo SM, et al. Iron replacement therapy in the routine management of blood donors. Transfusion 2012;52:1566-75.
9. Marks DC, Speedy J, Robinson KL, et al. An 8-week course of 45 mg of carbonyl iron daily reduces iron deficiency in female whole blood donors aged 18 to 45 years: results of a prospective randomized controlled trial. Transfusion 2014;54:780-8.
10. Mast A, Bialkowski W, Bryant B, et al. A randomized, blinded placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion 2016;56:1588-97.
11. Kiss JE, Brambilla D, Glynn SA, et al. Oral iron supplementation after blood donation: a randomized clinical trial. JAMA 2015;313:575-83.
12. Cable RG, Brambilla D, Glynn SA, et al. Effect of iron supplementation on iron stores and total body iron after whole blood donation. Transfusion 2016;56:2005-12.
13. Radtke H, Tegtmeier J, Röcker L, et al. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion 2004;44:1427-32.
14. Goldman M, Uzicanin S, Scalia V, et al. Iron deficiency in Canadian blood donors. Transfusion 2014;54:775-9.
15. Røsvik AS, Hervig T, Wentzel-Larsen T, et al. Iron status in Norwegian blood donors: comparison of iron status in new blood donors registered in 1993-1997 and in 2005-2006. Vox Sang 2009;96:49-55.
16. Goldman M, Magnussen K, Gorlin J, et al. International Forum regarding practices related to donor haemoglobin and iron. Vox Sang 2016;111:449-55.
17. Goldman M, Uzicanin S, Scalia J, et al. Impact of informing donors of low ferritin results. Transfusion 2016;56:2193-8.
18. Gorlin J, Katz L, Elsmore D, et al. Prevalence of blood donor iron deficiency and feasibility of ferritin-based iron replacement: a blood collection agency based study. Vox Sang 2016;111:206-8.
19. O'Brien SF. Donor iron policy: from research to practice. Transfusion 2016;56:1496-8.